Hydrafacial Results Presentation Deck
($mm)
Gross Profit
Selling & Marketing
G&A
R&D
Net Sales ($mm)
$37.9
4Q20
4Q21
$56.8
37.0
25.0
1.9
4Q20
$23.0
15.9
11.0
0.9
$77.9
4Q21
4TH QUARTER COST DETAIL
Non-GAAP measure; please refer to the appendix for a reconciliation to the appropriate GAAP measure
Change
+$33.8
+21.1
+14.0
+1.0
% Sales
4Q21
72.9%
47.6%
32.2%
2.4%
10
4Q20
60.8%
42.0%
29.0%
2.3%
Change Commentary
+12.1%
+5.6%
+3.1%
+0.1%
$3.6
9.4%
H
4Q20
■
Increase driven by higher sales volumes, fixed cost
leverage, and distributor acquisition accretion, partially
offset by higher logistics costs
Higher investment in marketing and increased sales
commissions due to increase in sales
Increased spend on developing infrastructure for global
expansion, as well as one-time costs
Adjusted EBITDA ($mm)¹
Continued investment in innovative products and
services
-% margin
$8.5
10.9%
4Q21View entire presentation